Kymera opens up $150M PIPE fi­nanc­ing, thanks to un­ex­pect­ed of­fer from in­vestors

A group of investors — with the lead fund deliberately leaving its name out of the public view — just made an unsolicited financing offer of $150 million to Kymera Therapeutics, and it’s bound to raise a few eyebrows.